Cutler Group LP Quanterix Corp Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$21.15 - $27.96 $4,230 - $5,592	200 New	200 $5,000
Q1 2023 May 01, 2023	SELL	$10.12 - $14.91 $49,810 - $73,387	-4,922 Reduced 48.73%	5,178 $58,000
Q4 2022 Feb 07, 2023	BUY	$8.75 - $14.02 $83,125 - $133,190	9,500 Added 1583.33%	10,100 $139,000
Q2 2022 Aug 04, 2022	SELL	$15.06 - $30.65 $518,064 - $1.05 Million	-34,400 Reduced 98.29%	600 $9,000
Q1 2022 Apr 14, 2022	BUY	$23.26 - $42.41 $814,100 - $1.48 Million	35,000 New	35,000 $1.02 Million
Q4 2021 Jan 18, 2022	SELL	$37.54 - $57.51 $7,508 - $11,502	-200 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$45.91 - $59.67 $59,682 - $77,571	-1,300 Reduced 86.67%	200 $9,000
Q2 2021 Jul 19, 2021	BUY	$43.3 - $67.17 $64,949 - $100,755	1,500 New	1,500 $87,000

158

32.1M

39K

5.5K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $465M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.